CBIO FY 2017 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$337M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$263,541

Operating Income

-$34M

Net Income

-$33M

EPS (Diluted)

$-1.13

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$129M

Total Liabilities

$9M

Stockholders' Equity

$120M

Cash & Equivalents

$124M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$18,500	-100.0%
Gross Profit	-$263,541	$18,500	-1524.5%
Operating Income	-$34M	-$32M	-6.3%
Net Income	-$33M	-$32M	-4.6%